Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
3B Blackbio Dx Limited engages in the design, development, manufacturing, and commercialization of molecular diagnostic solutions for infectious diseases, oncology, human genetics and antimicrobial resistance in India. The company offers qPCR-based and lateral flow assays rapid tests and Next Gen Sequencing -based molecular diagnostic kits for accurate and reliable testing on patient samples under the TRUPCR, TRUNGS, TRURAPID, brand for testing on patient samples to diagnostics labs. It also offers agrochemical products; technical support and training services. 3B Blackbio Dx Limited was incorporated in 1972 and is headquartered in Bhopal, India.
Key Metrics
as of Sep 2026
Market Cap 1,253 Cr
P/E 22.60
Div Yield 0.27 %
Book Value โน378.00
52w High โน1,750.00
52w Low โน1,084.00
Face Value โน10.00
Quarterly Results
Rs. Crores ยท hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
33.49
35.43
50.35
33.90
22.23
22.50
25.39
29.15
19.43
23.00
17.67
19.18
14.28
Expenses
24.97
26.94
28.63
19.17
10.40
14.58
10.32
12.98
8.48
13.12
8.80
11.39
7.84
Operating Profit
8.52
8.49
21.72
14.73
11.83
7.92
15.07
16.17
10.95
9.88
8.87
7.79
6.44
OPM %
25.44
23.96
43.14
43.45
53.22
35.20
59.35
55.47
56.36
42.96
50.20
40.62
45.10
Other Income
6.14
10.15
5.59
5.51
4.32
4.94
3.01
3.44
3.69
4.19
2.63
2.75
2.96
Depreciation
1.34
3.89
0.38
0.58
0.28
0.28
0.27
0.27
0.27
0.30
0.32
0.24
0.19
Interest
0.10
0.10
0.09
0.04
0.01
0.04
0.02
0.03
0.01
0.04
0.03
0.04
0.02
Profit before tax
13.22
14.65
26.84
19.62
15.86
12.54
17.79
19.31
14.36
13.73
11.15
10.26
9.19
Tax %
32.07
33.11
16.39
23.34
20.30
35.89
24.17
22.99
21.31
35.98
23.68
26.02
21.55
Net Profit
8.98
9.81
22.44
15.04
12.65
8.04
13.49
14.87
11.30
8.79
8.51
7.58
7.21
EPS in Rs
11.10
11.14
25.32
17.14
14.67
9.79
15.61
17.07
12.97
10.33
10.16
10.46
9.71
Profit & Loss
Annual ยท Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
142.00 96.00 74.00 62.00 81.00 227.00 29.00 23.00 23.00 16.00 17.00 19.00
Expenses
85.00 46.00 41.00 33.00 44.00 77.00 20.00 16.00 18.00 14.00 16.00 18.00
Operating Profit
57.00 50.00 33.00 29.00 37.00 150.00 9.00 7.00 5.00 3.00 2.00 1.00
OPM %
40.00 52.00 44.00 47.00 46.00 66.00 32.00 31.00 23.00 16.00 9.00 7.00
Other Income
26.00 15.00 13.00 7.00 7.00 3.00 2.00 1.00 0.00 0.00 0.00 0.00
Interest
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00 1.00 1.00 1.00
Depreciation
5.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00
Profit before tax
77.00 64.00 44.00 35.00 43.00 152.00 10.00 7.00 5.00 1.00 0.00 0.00
Tax %
22.00 25.00 28.00 27.00 26.00 25.00 23.00 25.00 24.00 19.00 23.00 23.00
Net Profit
60.00 48.00 32.00 26.00 32.00 114.00 8.00 5.00 3.00 1.00 0.00 0.00
EPS in Rs
68.27 55.57 37.40 34.55 42.89 151.66 10.24 8.18 5.35 1.76 0.51 0.36
Dividend Payout %
7.00 7.00 8.00 8.00 24.00 6.00 7.00 6.00 9.00 17.00 0.00 0.00
Balance Sheet
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
9.00 9.00 9.00 9.00 7.00 7.00 7.00 6.00 6.00 6.00 6.00 6.00
Reserves
316.00 260.00 214.00 185.00 146.00 125.00 25.00 16.00 12.00 5.00 4.00 4.00
Borrowings
3.00 0.00 1.00 2.00 3.00 2.00 4.00 6.00 6.00 9.00 8.00 8.00
Other Liabilities
51.00 27.00 24.00 19.00 37.00 59.00 9.00 8.00 6.00 6.00 6.00 7.00
Total Liabilities
378.00 296.00 248.00 214.00 192.00 194.00 45.00 36.00 30.00 26.00 24.00 25.00
Fixed Assets
28.00 7.00 7.00 8.00 7.00 5.00 4.00 4.00 4.00 3.00 3.00 4.00
CWIP
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments
158.00 156.00 117.00 92.00 93.00 59.00 1.00 0.00 0.00 0.00 0.00 0.00
Other Assets
193.00 132.00 123.00 114.00 93.00 130.00 40.00 32.00 26.00 22.00 21.00 21.00
Total Assets
378.00 296.00 248.00 214.00 192.00 194.00 45.00 36.00 30.00 26.00 24.00 25.00
Cash Flows
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
52.00 43.00 27.00 20.00 37.00 98.00 7.00 4.00 2.00 1.00 1.00 0.00
Cash from Investing Activity
-24.00 -33.00 -20.00 15.00 -28.00 -70.00 -1.00 -1.00 -1.00 0.00 0.00 0.00
Cash from Financing Activity
-1.00 -3.00 -4.00 -5.00 -15.00 -2.00 1.00 -1.00 0.00 0.00 -1.00 0.00
Net Cash Flow
28.00 7.00 3.00 30.00 -6.00 26.00 7.00 2.00 1.00 0.00 0.00 0.00
Free Cash Flow
27.00 42.00 26.00 18.00 35.00 96.00 6.00 3.00 1.00 0.00 1.00 0.00
CFO/OP %
121.00 116.00 115.00 100.00 129.00 90.00 101.00 71.00 52.00 36.00 69.00 23.00
Ratios
Annual ยท Days / % โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
129.00 138.00 179.00 200.00 136.00 56.00 252.00 290.00 259.00 321.00 283.00 262.00
Inventory Days
187.00 124.00 141.00 164.00 โ โ โ โ โ 175.00 143.00 145.00
Days Payable
70.00 28.00 66.00 69.00 โ โ โ โ โ 186.00 203.00 218.00
Cash Conversion Cycle
245.00 235.00 253.00 296.00 136.00 56.00 252.00 290.00 259.00 310.00 223.00 188.00
Working Capital Days
143.00 169.00 215.00 241.00 162.00 65.00 275.00 287.00 253.00 247.00 205.00 175.00
ROCE %
25.00 26.00 21.00 19.00 27.00 162.00 31.00 28.00 24.00 13.00 7.00 7.00
Shareholding Pattern
% holding โ latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
40.95
40.94
41.27
41.28
41.28
41.28
41.28
41.28
41.28
41.29
38.43
38.43
FIIs
2.50
2.57
2.57
2.64
2.70
2.49
2.68
3.27
3.28
2.97
3.38
3.16
DIIs
2.15
1.98
1.87
1.82
1.76
1.60
1.74
1.96
1.96
1.89
1.18
0.82
Public
54.40
54.50
54.27
54.26
54.28
54.64
54.29
53.48
53.48
53.85
56.99
57.60
No. of Shareholders
11,049
10,616
10,507
10,709
10,619
10,345
10,166
9,586
9,399
9,753
10,088
10,513
Corporate Actions
12 records
Back to all stocks